Post-effective amendment to a registration statement that is not immediately effective upon filing

Stock-Based Compensation - Schedule of Stock Option Activity (Details)

v3.22.1
Stock-Based Compensation - Schedule of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]      
Options Available for Grant, Beginning Balance 499,133 2,822,165  
Options Available for Grant, Additional shares authorized   9,273,082  
Options Available for Grant, Options canceled and forfeited   2,632,413  
Options Available for Grant, Repurchases   75,633  
Options Available for Grant, Options granted   (14,304,160)  
Options Available for Grant, Ending Balance 499,133 499,133 2,822,165
Number of Options, Beginning Balance 24,576,860 13,613,627  
Number of Options, Options canceled and forfeited (1,334,118) (2,632,413)  
Number of Options, Options granted 445,353 14,304,160  
Number of Options, Options exercised (2,435,543) (708,514)  
Number of Options, Ending Balance 21,252,552 24,576,860 13,613,627
Number of Options, Vested and expected to vest 21,252,552    
Number of Options, Shares exercisable (vested and unvested) 7,642,374    
Weighted- Average Exercise Price Per Share, Beginning Balance $ 0.66 $ 0.20  
Weighted- Average Exercise Price Per Share, Options canceled and forfeited 0.82 0.26  
Weighted- Average Exercise Price Per Share, Options granted 0.01 1.02  
Weighted- Average Exercise Price Per Share, Options exercised 0.49 0.54  
Weighted- Average Exercise Price Per Share, Ending Balance 0.66 $ 0.66 $ 0.20
Weighted- Average Exercise Price Per Share, Vested and expected to vest 0.66    
Weighted average exercise price per share, Shares exercisable (vested and unvested) $ 0.61    
Weighted-average remaining contractual term, Balances 7 years 11 months 12 days 9 years 21 days 9 years 4 months 13 days
Weighted Average Remaining Contractual Term, Vested and expected to vest 7 years 11 months 12 days    
Weighted Average Remaining Contractual Term, Shares exercisable (vested and unvested) 7 years 7 months 6 days    
Aggregate Intrinsic Value, Beginning Balance $ 187,460 $ 28,762  
Aggregate Intrinsic Value, Ending Balance 141,137 $ 187,460 $ 28,762
Aggregate Intrinsic Value, Vested and expected to vest 141,137    
Shares exercisable (vested and unvested) $ 51,089